← Leaderboards
Shannon Rose McCurdy
University Of Pennsylvania
$568,000
Attributed
$568,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $243K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$568,000 · 2
By mechanism
R03$325,000 · 1
K76$243,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Paul L Stein$3,983,578
- Claudia D Andl$2,474,065
- Meenhard Herlyn$50,214,821
- Michael R King$8,012,934
- Daria Babushok$1,940,612
Others in their field
Other Rising Stars on “Myeloproliferative Disease”
- Angela Goffredo Fleischman · University Of California-Irvine$3,079,952
- Jing Yang · Aplexis, Inc.$2,599,872
- Heather Leigh Herd Gustafson · Seattle Children'S Hospital$2,399,099
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Jeevisha Bajaj · University Of Rochester$1,754,424
- Jonathan Lyons · University Of California, San Diego$1,565,919
Research focus
Myeloproliferative DiseaseOlder PatientFutureMortalityNewly DiagnosedObservational StudyCd28 GeneFrailtyHematopoietic NeoplasmsIncidenceElderlyNatural Killer CellsAzacitidineAcute Myelocytic LeukemiaBiological MarkersAgingAging PopulationFda ApprovedDisease RemissionGeriatric AssessmentAllogenicBlood SpecimenAffectPhenotype
Grant awards (3)
The Impact of Frailty on Disease Relapse and Therapy Intensity in Older Adults with Acute Myeloid Leukemia: Biomarkers and Treatment Selection$243,000
K76 · FY2025 · AG · contact PI
Optimizing Allogeneic Hematopoietic Cell Transplantation for Older Patients with Hematologic Malignancies$162,500
R03 · FY2023 · AG · contact PI
Optimizing Allogeneic Hematopoietic Cell Transplantation for Older Patients with Hematologic Malignancies$162,500
R03 · FY2022 · AG · contact PI